Ra Capital Management as of Dec. 31, 2024
Portfolio Holdings for Ra Capital Management
Ra Capital Management holds 89 positions in its portfolio as reported in the December 2024 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Ascendis Pharma A/s - SH (ASND) | 18.5 | $1.4B | 10M | 137.67 | |
| Vaxcyte SH (PCVX) | 9.5 | $711M | 8.7M | 81.86 | |
| Janux Therapeutics SH (JANX) | 7.4 | $555M | 10M | 53.54 | |
| Rhythm Pharmaceuticals SH (RYTM) | 4.5 | $341M | 6.1M | 55.98 | |
| Legend Biotech Corp- SH (LEGN) | 3.3 | $244M | 7.5M | 32.54 | |
| Edgewise Therapeutics SH (EWTX) | 3.2 | $238M | 8.9M | 26.70 | |
| Newamsterdam Pharma Co Nv SH (NAMS) | 3.0 | $227M | 8.8M | 25.70 | |
| Wave Life Sciences SH (WVE) | 3.0 | $225M | 18M | 12.37 | |
| Arcellx SH (ACLX) | 2.8 | $214M | 2.8M | 76.69 | |
| Avidity Biosciences SH (RNA) | 2.4 | $183M | 6.3M | 29.08 | |
| Septerna SH (SEPN) | 2.1 | $160M | 7.0M | 22.90 | |
| Dyne Therapeutics SH (DYN) | 2.0 | $150M | 6.4M | 23.56 | |
| Tyra Biosciences SH (TYRA) | 2.0 | $148M | 11M | 13.90 | |
| Rxsight SH (RXST) | 1.7 | $129M | 3.7M | 34.38 | |
| Bicara Therapeutics SH (BCAX) | 1.6 | $121M | 7.0M | 17.42 | |
| Lenz Therapeutics SH (LENZ) | 1.6 | $121M | 4.2M | 28.87 | |
| Ars Pharmaceuticals SH (SPRY) | 1.5 | $115M | 11M | 10.55 | |
| 89bio SH (ETNB) | 1.5 | $111M | 14M | 7.82 | |
| Spdr S&p Biotech Etf SH (XBI) | 1.5 | $111M | 1.2M | 90.06 | |
| Geron Corp SH (GERN) | 1.4 | $106M | 30M | 3.54 | |
| Artiva Biotherapeutics SH (ARTV) | 1.3 | $99M | 9.9M | 10.08 | |
| Axsome Therapeutics SH (AXSM) | 1.1 | $85M | 1.0M | 84.61 | |
| Verona Pharma Plc - SH (VRNA) | 1.1 | $82M | 1.8M | 46.44 | |
| Day One Biopharmaceuticals I SH (DAWN) | 1.0 | $73M | 5.8M | 12.67 | |
| Apogee Therapeutics SH (APGE) | 0.9 | $71M | 1.6M | 45.30 | |
| Mineralys Therapeutics SH (MLYS) | 0.8 | $60M | 4.9M | 12.31 | |
| Praxis Precision Medicines I SH (PRAX) | 0.8 | $59M | 762k | 76.96 | |
| Climb Bio SH (CLYM) | 0.8 | $57M | 31M | 1.80 | |
| Recursion Pharmaceuticals-a SH (RXRX) | 0.7 | $52M | 7.7M | 6.76 | |
| Tourmaline Bio SH (TRML) | 0.7 | $52M | 2.5M | 20.28 | |
| Acrivon Therapeutics SH (ACRV) | 0.7 | $50M | 8.3M | 6.02 | |
| Fulcrum Therapeutics SH (FULC) | 0.6 | $48M | 10M | 4.70 | |
| 10x Genomics Inc-class A SH (TXG) | 0.6 | $47M | 3.3M | 14.36 | |
| Gh Research SH (GHRS) | 0.6 | $47M | 6.7M | 7.00 | |
| Astria Therapeutics SH (ATXS) | 0.6 | $46M | 5.1M | 8.94 | |
| Vor Biopharma SH (VOR) | 0.6 | $44M | 40M | 1.11 | |
| Structure Therapeutics SH (GPCR) | 0.5 | $41M | 1.5M | 27.12 | |
| Dianthus Therapeutics SH (DNTH) | 0.5 | $41M | 1.9M | 21.80 | |
| Pepgen SH (PEPG) | 0.5 | $41M | 11M | 3.79 | |
| Evolent Health Inc - A SH (EVH) | 0.5 | $40M | 3.6M | 11.25 | |
| Kura Oncology SH (KURA) | 0.5 | $39M | 4.5M | 8.71 | |
| Ideaya Biosciences SH (IDYA) | 0.5 | $35M | 1.3M | 25.70 | |
| Zai Lab Ltd- SH (ZLAB) | 0.5 | $34M | 1.3M | 26.19 | |
| Chimerix SH (CMRX) | 0.4 | $31M | 8.8M | 3.48 | |
| Cidara Therapeutics SH (CDTX) | 0.4 | $29M | 1.1M | 26.88 | |
| Mbx Biosciences SH (MBX) | 0.4 | $28M | 1.5M | 18.43 | |
| Nkarta SH (NKTX) | 0.4 | $27M | 11M | 2.49 | |
| Acumen Pharmaceuticals SH (ABOS) | 0.3 | $26M | 15M | 1.72 | |
| 4d Molecular Therapeutics In SH (FDMT) | 0.3 | $25M | 4.6M | 5.57 | |
| Nurix Therapeutics SH (NRIX) | 0.3 | $25M | 1.3M | 18.84 | |
| Sera Prognostics Inc-a SH (SERA) | 0.3 | $25M | 3.0M | 8.14 | |
| Aerovate Therapeutics SH (AVTE) | 0.3 | $24M | 9.2M | 2.65 | |
| Eyepoint Pharmaceuticals SH (EYPT) | 0.3 | $24M | 3.2M | 7.45 | |
| Larimar Therapeutics SH (LRMR) | 0.3 | $23M | 6.0M | 3.87 | |
| Ceribell SH (CBLL) | 0.3 | $21M | 825k | 25.88 | |
| Travere Therapeutics SH (TVTX) | 0.3 | $20M | 1.2M | 17.42 | |
| Enliven Therapeutics SH (ELVN) | 0.3 | $19M | 849k | 22.50 | |
| Taysha Gene Therapies SH (TSHA) | 0.3 | $19M | 11M | 1.73 | |
| Alector SH (ALEC) | 0.2 | $18M | 9.7M | 1.89 | |
| Protara Therapeutic SH (TARA) | 0.2 | $18M | 3.4M | 5.28 | |
| C4 Therapeutics SH (CCCC) | 0.2 | $18M | 4.9M | 3.60 | |
| Solid Biosciences SH (SLDB) | 0.2 | $17M | 4.3M | 4.00 | |
| Pliant Therapeutics SH (PLRX) | 0.2 | $17M | 1.3M | 13.17 | |
| Bright Minds Biosciences SH (DRUG) | 0.2 | $17M | 461k | 36.02 | |
| Iteos Therapeutics SH | 0.2 | $16M | 2.1M | 7.68 | |
| Bicycle Therapeutics Plc- SH (BCYC) | 0.2 | $15M | 1.1M | 14.00 | |
| Eledon Pharmaceuticals SH (ELDN) | 0.2 | $15M | 3.6M | 4.12 | |
| Insmed SH (INSM) | 0.2 | $14M | 200k | 69.04 | |
| Xencor SH (XNCR) | 0.2 | $13M | 575k | 22.98 | |
| Immatics Nv SH (IMTX) | 0.2 | $12M | 1.8M | 7.11 | |
| Aclaris Therapeutics SH (ACRS) | 0.2 | $12M | 4.7M | 2.48 | |
| Monopar Therapeutics SH (MNPR) | 0.1 | $11M | 511k | 22.00 | |
| Third Harmonic Bio SH (THRD) | 0.1 | $9.9M | 961k | 10.29 | |
| Werewolf Therapeutics SH (HOWL) | 0.1 | $9.1M | 6.1M | 1.48 | |
| Arvinas SH (ARVN) | 0.1 | $8.1M | 421k | 19.17 | |
| Zura Bio SH (ZURA) | 0.1 | $8.0M | 3.2M | 2.50 | |
| Perceptive Capital Solutions SH (PCSC) | 0.1 | $7.6M | 750k | 10.18 | |
| Bioage Labs SH (BIOA) | 0.1 | $7.6M | 1.3M | 5.79 | |
| Adicet Bio SH (ACET) | 0.1 | $7.3M | 7.5M | 0.96 | |
| Avalo Therapeutics SH (AVTX) | 0.1 | $7.2M | 967k | 7.43 | |
| Boundless Bio SH (BOLD) | 0.1 | $6.3M | 2.2M | 2.90 | |
| Enanta Pharmaceuticals SH (ENTA) | 0.1 | $6.0M | 1.0M | 5.75 | |
| Newamsterdam Pharma Co Nv-27 SH (NAMSW) | 0.1 | $4.7M | 333k | 14.25 | |
| Surrozen SH (SRZN) | 0.1 | $4.1M | 283k | 14.35 | |
| Lexeo Therapeutics SH (LXEO) | 0.0 | $3.6M | 547k | 6.58 | |
| Allakos SH | 0.0 | $1.4M | 1.1M | 1.21 | |
| Scholar Rock Holding Corp SH (SRRK) | 0.0 | $761k | 18k | 43.22 | |
| Regulus Therapeutics SH | 0.0 | $532k | 337k | 1.58 | |
| Scilex Holding SH | 0.0 | $442k | 1.0M | 0.43 |
